USU Researcher Shares $12.2 Million to Study Chlamydia trachomatis

What may be the most comprehensive study of the sexually transmitted bacterium Chlamydia trachomatis is now underway, thanks to a $12.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. The multi-institutional five-year study will perform molecular genomics analyses of the disease-causing powers of Chlamydia on a scale never before attempted. Anthony T. Maurelli, Ph.D., department of Microbiology and Immunology of the F. Edward Hébert School of Medicine at the Uniformed Services University of the Health Sciences, along with Patrik Bavoil, Ph.D. and Jacques Ravel, Ph.D., both at the University of Maryland, Baltimore (UMB), will lead the study.